Filing Details

Accession Number:
0001104659-22-062607
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-18 19:01:55
Reporting Period:
2022-05-16
Accepted Time:
2022-05-18 19:01:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1737953 Replimune Group Inc. REPL Biological Products, (No Disgnostic Substances) (2836) 822082553
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1860609 Sushil Patel C/O Replimune Group, Inc.
500 Unicorn Park Drive
Woburn MA 01801
Chief Commercial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-05-16 10,687 $14.59 130,146 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.
  2. The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.59 to $14.62. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.